ADSL and osteomyelitis: The AMP PL‐5 spray was clinically determined to be a safe and effective treatment for skin wound infections.[5] Similarly, human lactoferrin N‐terminal 11‐peptide (hLF1‐11) has been shown to be effective in animal models of osteomyelitis and other bacterial infections, with significant efficacy observed in phase I trials.[6] AMPs have been shown to have good antibacterial properties.